Cardinal Health stock price

카디널 헬스NYSE:CAH · New York Stock Exchange · Healthcare
$228.30-0.78%
2026-10-02 close
Loading chart…

Today's signals · MACD bullish cross

Signal details →

Cardinal Health last closed at $228.30 (-0.78%) on 2026-10-02. Signals today: MACD bullish cross. Listed on New York Stock Exchange. Trailing 12 months PER is 31.6×. Its overall grade ranks 42 of 739 stocks in Healthcare.

About this company

Cardinal Health last closed at $228.30 (-0.78%) on 2026-10-02. Signals today: MACD bullish cross. Listed on New York Stock Exchange.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall A+ · 42/739

Valuation grade B+

Details →

Dividends

2025 dividend per share · $2.03 · Yield 0.92%

Details →

Related stocks

  • McKessonCompetitor

    미국 최대 의약품 유통·헬스케어 서비스 경쟁사

  • CencoraCompetitor

    대형 의약품 유통 및 전문의약품 서비스 경쟁사

  • Walgreens Boots AllianceCustomer

    약국·소매 유통 채널로 의약품과 헬스케어 제품을 공급받는 주요 고객

Details →

ETFs holding this stock

Liberty One Defensive Dividend Growth ETF · Brown Advisory Sustainable Value ETF · Liberty One Tactical Income ETF

Details →
About Cardinal Health
What technical signals does Cardinal Health (CAH) have?
Cardinal Health current technical signals: MACD bullish cross.
Is Cardinal Health a cup-and-handle pattern?
No. Cardinal Health has no valid Cup signal right now.
What published figures are available for Cardinal Health?
Market cap: $54.76B. Trailing 12 months PER: 31.6×. Latest quarter PBR: -19.86×. Dividend yield: 0.92%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Major stocks in the same sector

2026-10-03 dataset

Turn what you saw on this name into a strategy

Ask Q about Cardinal Health, or open the plan table on the main site.

From the names you found, through to a scheduled run

Set the conditions and they run at the scheduled time (live orders are not open yet).

See plans ↗

Cardinal Health notifications

Quantus Signal · live data · not investment advice · Privacy Policy